49 results
20-F/A
2023 FY
CYTO
Altamira Therapeutics Ltd
22 Apr 24
Annual report (foreign) (amended)
4:31pm
to all holders of shares whose shares are being acquired.
Anti-Takeover Provisions
Two-thirds supermajority shareholder voting requirement: Our Bye … corporation to include in its certificate of incorporation a supermajority voting requirement in connection with dissolutions initiated by the board.
A Bermuda
424B5
CYTO
Altamira Therapeutics Ltd
19 Jan 24
Prospectus supplement for primary offering
4:40pm
offers the same terms to all holders of shares whose shares are being acquired.
Anti-Takeover Provisions
Two-thirds supermajority shareholder voting … of incorporation a supermajority voting requirement in connection with dissolutions initiated by the board.
A Bermuda company may be wound up by the Bermuda court
424B5
9c4mcw qd4
8 Dec 21
Prospectus supplement for primary offering
4:37pm
F-3
i3z5fm7rqglu8 2m
16 Nov 21
Shelf registration (foreign)
5:05pm
424B5
yefa0t aa0yhk
15 Jan 21
Prospectus supplement for primary offering
4:32pm
424B5
3nt2 nvhz
3 Dec 20
Prospectus supplement for primary offering
5:25pm
424B4
audds60 7epq
14 May 19
Prospectus supplement with pricing info
4:06pm
F-1/A
9xu3g
10 May 19
Registration statement (foreign) (amended)
3:18pm
F-1/A
temvg
6 May 19
Registration statement (foreign) (amended)
5:26pm
F-1
lirlcs7tjcsfdcuiw6rf
30 Apr 19
Registration statement (foreign)
8:32am